Charles River Laboratories | CRL - Заемный капитал





Заемный капитал Изменить Дата
Agilent USD 3.05B 1000K 2026-03
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Cardinal Health USD 8.25B 102M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Cigna USD 29.37B 1.5B 2026-03
Concord Medical Services Hldg CNY 2.27B 3.79M 2025-06
CVS Health USD 60.53B 29M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Elevance Health USD 30.77B 29M 2026-03
Humana USD 12.27B 95M 2026-03
Illumina USD 1.49B 0 2026-03
Incyte USD 29.41M 785K 2026-03
Intrexon USD 0 198.67M 2024-06
IQVIA Holdings USD 13.99B 105M 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Lonza CHF 3.88B 323M 2025-12
McKesson USD 5.26B 166M 2026-03
Merck EUR 10.8B 72M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Quest Diagnostics USD 5.16B 12M 2026-03
Revvity USD 2.63B 836K 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
United Therapeutics USD 100M 100M 2024-06
UnitedHealth USD 71.44B 880M 2026-03
Veradigm USD 200.4M 69K 2022-12
Waters USD 5.22B 3.81B 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03